 |
|
|
|
November 2000 Cover
|
|
A multicenter team reports that a combination of abacavir and amprenavir can suppress HIV replication
and stabilize CD4 T-cell counts when given soon after infection. A study of 41 HIV-infected patients who
were antiretroviral-naive and 49 controls showed that virus replication was suppressed in the HIV-positive patients
in comparable numbers to HIV-negative subjects in about 24 to 48 weeks. Scientists also noted that the
patients' triglyceride and cholesterol levels remained good after 72 weeks.
Editor's Note: from Reuters Health Info Services
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
